Qkine Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.24M

  • Investors
  • 16

Qkine General Information

Description

Manufacturer of cytokines and complex proteins intended to advance stem cell, organoid, and regenerative medicines. The company manufactures high-purity, animal-free growth factors, cytokines, and proteins for life science applications, including organoid culture, and combines proprietary production processes with protein engineering technology to tackle fundamental biological and scale-up challenges, enabling clients with the highest purity, bioactive proteins to support its customers best and maximize the impact of their science.

Contact Information

Website
www.qkine.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Murdoch House
  • Garlic Row
  • Cambridge CB5 8HW
  • England, United Kingdom
+44 01223
Primary Industry
Biotechnology
Other Industries
Other Commercial Products
Corporate Office
  • 1 Murdoch House
  • Garlic Row
  • Cambridge CB5 8HW
  • England, United Kingdom
+44 01223

Qkine Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qkine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 02-Sep-2026 $3.24M Completed Generating Revenue
10. Secondary Transaction - Private 01-Jun-2026 Completed Generating Revenue
9. Later Stage VC 21-Mar-2025 Completed Generating Revenue
8. Later Stage VC 15-Dec-2022 Completed Generating Revenue
7. Grant 01-Jan-2021 Completed Generating Revenue
6. Early Stage VC (Series A) 08-Jun-2020 Completed Generating Revenue
5. Seed Round 01-May-2019 Completed Generating Revenue
4. Accelerator/Incubator 10-Jan-2019 Completed Generating Revenue
3. Seed Round 23-Apr-2018 $198K $198K Completed Generating Revenue
2. Grant 01-Dec-2017 $90.6K Completed Startup
To view Qkine’s complete valuation and funding history, request access »

Qkine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 1,051,282 $0.000135 $2.64 $2.64 1x $2.64 22.89%
Ordinary 112,000 $0.000135 $1.69 $1.69 1x $1.69 2.44%
To view Qkine’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Qkine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of cytokines and complex proteins intended to advance stem cell, organoid, and regenerative medicines. The
Biotechnology
Cambridge, United Kingdom
35 As of 2026

Minneapolis, MN
 

Trumbull, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Qkine Competitors (9)

One of Qkine’s 9 competitors is R&D Systems, a Corporate Backed or Acquired company based in Minneapolis, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
R&D Systems Corporate Backed or Acquired Minneapolis, MN
ARVYS Proteins Corporation Trumbull, CT
ProSpec-Tany TechnoGene Corporation East Brunswick, NJ
PeproTech Corporate Backed or Acquired Cranbury, NJ
STEMCELL Technologies Private Debt Financed Vancouver, Canada
You’re viewing 5 of 9 competitors. Get the full list »

Qkine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qkine Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cambridge Angels Angel Group Minority
Centre for Process Innovation Corporate Venture Capital Minority
EMV Capital Venture Capital Minority
EverQuest Capital Partners PE/Buyout Minority
Meltwind Advisory Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Qkine FAQs

  • When was Qkine founded?

    Qkine was founded in 2016.

  • Where is Qkine headquartered?

    Qkine is headquartered in Cambridge, United Kingdom.

  • What is the size of Qkine?

    Qkine has 35 total employees.

  • What industry is Qkine in?

    Qkine’s primary industry is Biotechnology.

  • Is Qkine a private or public company?

    Qkine is a Private company.

  • What is the current valuation of Qkine?

    The current valuation of Qkine is .

  • What is Qkine’s current revenue?

    The current revenue for Qkine is .

  • How much funding has Qkine raised over time?

    Qkine has raised $12.9M.

  • Who are Qkine’s investors?

    Cambridge Angels, Centre for Process Innovation, EMV Capital, EverQuest Capital Partners, and Meltwind Advisory are 5 of 16 investors who have invested in Qkine.

  • Who are Qkine’s competitors?

    R&D Systems, ARVYS Proteins, ProSpec-Tany TechnoGene, PeproTech, and STEMCELL Technologies are some of the 9 competitors of Qkine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process